Search Results 101-110 of 15111 for Break STD Taboo

1. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

   GVHD is the most common serious complication, after bone marrow transplant. GVHD occurs when the donor cells (the graft), treat the recipient's body as "foreign ...

2. Deb Balzer | Mayo Clinic News Network - Page 53 of 72

   Infectious Diseases A-Z: Avoid illness during spring break at the beach ... March is a traditional travel month for thousands of college students and families as ...

3. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   This randomized phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based ...

4. Obstetrics and Gynecology Clinical Trials - Medical Professionals

   The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and ...

5. Family planning: Get the facts about pregnancy spacing - Mayo Clinic

   The amount of time between pregnancies may have health effects. As you plan for your next pregnancy, learn about the impact pregnancy timing can have.

6. Obstetrics and Gynecology Clinical Trials - Medical Professionals

   The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and ...

7. Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE) - Mayo Clinic

   The purpose of the study is to evaluate the effectiveness, safety and patient-reported outcomes of peptide receptor radionuclide therapy (PRRT) with 177Lu- ...

8. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   The purpose of this study is to evaluate the addition of 2 years of palbociclib to standard adjuvant endocrine therapy for patients with HR+ / HER2- early ...

9. Jason Howland: Dr. Elizabeth Cozine, a Mayo Clinic family physician, says the Centers for Disease Control and Prevention has a standard immunization schedule ...

10. Debunking COVID-19 myths - Mayo Clinic

    Once the protein pieces are made, the cells break down the instructions and get rid of them. The mRNA from the vaccine doesn't enter the nucleus of the cell ...